Publications for Magdy El-Salhy
Co-author map based on ISI articles 2007-
Journal Articles
Jussi Rauma, Anna Spångéus and Magdy El-Salhy
Ghrelin cell density in the gastrointestinal tracts of animal models of human diabetes.
Histology and Histopathology, 2006, 21(1), 1-5.
Web of Science® Times Cited: 7 |
Magdy El-Salhy
Combined treatment with octreotide, Galanin and serotonin in gastrointestinal malignancies
Letters in Drug Design & Discovery, 2005, 2(6), 439-443.
|
Magdy El-Salhy
Triple treatment with octreotide, galanin and serotonin is a promising therapy for colorectal cancer
Current pharmaceutical design, 2005, 11(16), 2107-2117.
Web of Science® Times Cited: 11 |
Magdy El-Salhy, L Hilding, H Royson and Veronica Tjomsland
Comparison between triple therapy with octreotide, galanin and serotonin vs. irinotecan or oxaliplatin in combination with 5-fluorouracil/leukovorin in human colon cancer.
International Journal of Oncology, 2005, 27(3), 687-691.
Web of Science® Times Cited: 7 |
Veronica Tjomsland and Magdy El-Salhy
Anti-tumour effects of triple therapy with octreotide, galanin and serotonin in comparison with those of 5-fluorouracil/leukovorin on human colon cancer.
International Journal of Oncology, 2005, 27(2), 427-432.
Web of Science® Times Cited: 4 |
Magdy El-Salhy
Effects of triple therapy with octreotide, galanin and serotonin on a human colon cancer cell line implanted in mice: Comparison between different routes of administration
Histology and Histopathology, 2005, 20(1), 19-25.
Web of Science® Times Cited: 5 |
Vegard Tjomsland and Magdy El-Salhy
Effects of single, double or triple combinations of octreotide, galanin and serotonin on a human pancreatic cancer cell line
Histology and Histopathology, 2005, 20(2), 537-541.
Web of Science® Times Cited: 4 |
Magdy El-Salhy
Effects of octreotide, galanin and serotonin on a human gastric cancer cell line.
Oncology Reports, 2005, 13(5), 787-791.
Web of Science® Times Cited: 4 |
Magdy El-Salhy, Vegard Tjomsland and Elvar Theodorsson
Effects of triple treatment with octreotide, galanin and serotonin on a human pancreas cancer cell line in xenografts
Histology and Histopathology, 2005, 20(3), 745-752.
Web of Science® Times Cited: 4 |
Magdy El-Salhy
Effects of triple therapy with octreotide, galanin and serotonin on a human colon cancer cell line.
Oncology Reports, 2005, 13(1), 45-49.
Web of Science® Times Cited: 2 |
Magdy El-Salhy
Comparison between triple therapy with octreotide, galanin and serotonin, 5-fluorouracil/leucovorin, and sequential treatment with both, on human colon cancer.
Oncology Reports, 2004, 11(6), 1161-1168.
Web of Science® Times Cited: 7 |
Magdy El-Salhy and Veronica Dennerqvist
Effects of triple therapy with octreotide, galanin and serotonin on liver metastasis of human colon cancer in xenografts.
Oncology Reports, 2004, 11(6), 1177-1182.
Web of Science® Times Cited: 14 |
Magdy El-Salhy and Anna Starefeldt
Direct effects of octreotide, galanin and serotonin on human colon cancer cells.
Oncology Reports, 2003, 10, 1723-1728.
|
Magdy El-Salhy, Basel Sitohy and Örjan Norrgård
Triple therapy with octreotide, galanin, and serotonin reduces the size and blood vessel density and increases apoptosis of a rat colon carcinoma.
Regulatory Peptides, 2003, 111, 145-152.
|
B Sitohy and Magdy El-Salhy
A comparison between double and triple therapies of octreotide, galanin and serotonin on a rat colon carcinoma.
Histology and Histopathology, 2003, 18, 103-110.
|
Magdy El-Salhy
Chronic idiopathic slow transit constipation: pathophysiology and management.
Colorectal Disease, 2003, 5, 288-296.
|
Books
Ph.D., Lic. Theses
